Genomics Services
 
 
Warfarin
It is the most prescribed anticoagulant in long treatment of and prevention of thrombolic events in patients. Overdosing and under dosing of warfarin can result into bleeding and thrombosis. Metabolism of warfarin is controlled both by CYP2C9 and VKORC1 genes respectively. The genetic polymorphism of CYP2C9 and VKORC1 shows diversities in the maintained dose of warfarin in individual patients. Identification of inherited variants of these genes is significant to optimize warfarin doses that reduces the time needed to achieve a therapeutic INR (International Normalized Ratio). Genetic testing before therapy initiation aids in corrective initial dosing.

Sample Type

Blood Sample: 5 ml blood in EDTA Vacutainer at 2-8°C
 
Brochure           inquiry
 
 
MYBPC3 Test (For Hypertropic Cardiomyopathy)   |   SLCO1B1 Test (For Statin Induced Myopathy)
Warfarin   |   Clopidogrel
 
 
Click Here to Zoom
 
Click Here to Zoom
 
Click Here to Zoom
 
Click Here to Zoom